Portefeuille d'ETF LABU (NYSE) - Page 2 | MetaTrader

Afficher le graphique complet Full chart

Aperçu Toutes les participations Heatmap

Principaux titres en portefeuille Market Value Shares Weight %

IONS Ionis Pharmaceuticals, Inc. 4.1 M 49.1 K 0.7%

CYTK Cytokinetics Inc 4.0 M 64.0 K 0.7%

GRAL GRAIL Inc 4.0 M 40.7 K 0.7%

REGN Regeneron Pharmaceuticals, Inc. 3.9 M 5 313.0 0.7%

PTCT PTC Therapeutics, Inc. 3.9 M 52.1 K 0.7%

Avidity Biosciences Inc. 3.9 M 54.1 K 0.7%

BIIB Biogen Inc 3.9 M 21.7 K 0.7%

Exact Sciences Corporation 3.9 M 38.1 K 0.7%

EXEL Exelixis, Inc. 3.9 M 94.0 K 0.7%

ARWR Arrowhead Pharmaceuticals Inc 3.9 M 56.0 K 0.7%

NTRA Natera Inc. 3.8 M 16.6 K 0.7%

ABBV AbbVie Inc. 3.8 M 17.1 K 0.7%

SRRK Scholar Rock Holding Corp. 3.8 M 85.7 K 0.7%

RYTM Rhythm Pharmaceuticals Inc 3.8 M 36.8 K 0.7%

UTHR United Therapeutics Corporation 3.7 M 7 959.0 0.6%

TGTX TG Therapeutics Inc 3.7 M 126.1 K 0.6%

CGON CG Oncology Inc. 3.7 M 70.4 K 0.6%

TVTX Travere Therapeutics Inc 3.5 M 112.3 K 0.6%

PTGX Protagonist Therapeutics Inc 3.5 M 42.2 K 0.6%

MDGL Madrigal Pharmaceuticals Inc 3.4 M 6 985.0 0.6%

1
2
3
4
5
6
7
8

Nouvelles

First Quarter Earnings: Sharpening Sector Divergence

3 Reasons To Stick With Growth Stocks In Rotating Markets

Seeking Innovation Beyond Tech? Insight On Healthcare Stocks

Makary's Successor Faces Tough Task Managing FDA Amid Budget Cuts

What's The Dominant Trend In Earnings: AI Or Geopolitics?

Medical Technology Stocks: Innovation Endures As Valuations Reset

AI And The Future Of Healthcare

Global PMI: Tracking The Sectors Hit Hardest By The Middle East War

Can Forgotten Biotech Break Out?

Concerns Shift From Obsolescence To Oil

CDT Insider Sentiment March 2026: The Probability Race And Barbell Strategies

Finally Coming Into View? 'Old-Economy' Stocks Show Their Colors